Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
Lilly will license certain baricitinib manufacturing know-how to enable EVA Pharma to manufacture and supply treatment for various immunological diseases
The recent inspection covered both cGMP and PAI processes
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
The JV will establish a state-of-the-art manufacturing facility to manufacture fermented animal free protein to cater to the global markets
Subscribe To Our Newsletter & Stay Updated